Menarini Silicon Biosystems Announces study results to be presented at American Society of Hematology (ASH) Annual Meeting Highlighting CELLSEARCH® CMMC assay, a Non-Invasive Liquid Biopsy for the Quantification and Molecular Characterization of Circulating Multiple Myeloma Cells
Topics: CELLSEARCH, Liquid biopsy, Multiple myeloma, Dana-Farber Cancer Institute, Multiple Myeloma Research Foundation
As the market leader in cell-based liquid biopsies, Menarini Silicon Biosystems is offering community hematology-oncologists an opportunity to have patient blood samples sent to a US centralized laboratory where its CELLSEARCH® technology can enumerate Circulating Multiple Myeloma Cells (CMMCs) for non-invasive monitoring of disease
Topics: CELLSEARCH, Liquid biopsy, Multiple myeloma, CLIA Lab, LDT
CELLMAG – a cost effective, manual and simple approach for the enrichment and staining of extremely rare cells from blood
Topics: CTCs, CELLSEARCH, Liquid biopsy, Blood Enrichment, CellMag
Developments for CELLSEARCH and DEPArray Technologies to be Featured at the Molecular Medicine Tri-Conference
Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, rare cells
Northwestern University researchers use gold standard liquid-biopsy technology to deepen understanding of metastatic breast cancer
Topics: Liquid biopsy, Precision Medicine, Circulating tumor cells, metastatic breast cancer, rare cells
Automated volume reduction instrument increases precision and accuracy in rare cell workflows
Topics: Liquid biopsy, Precision Medicine, rare cells, volume reduction, VRNxT
09/23/2019
World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer
Topics: CTCs, Liquid biopsy, Precision Medicine, rare cells
Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis
Topics: CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer
03/27/2019
Northwestern Researchers Use Gold-Standard Liquid Biopsy Technology to Identify Potential New Biomarker
Topics: deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, metastatic breast cancer, lynphoma, CTC cluster, melanoma
03/12/2019
Technology to Be Introduced at the Molecular Medicine Tri-Conference May Offer Alternative to Invasive Bone Marrow Biopsy for Monitoring Disease Progression
Topics: FFPE, deparray, CELLSEARCH, Liquid biopsy, Precision Medicine, Multiple myeloma, CMMCs
©2020 Menarini Silicon Biosystems. All rights reserved. This site is published by Menarini Silicon Biosystems which is solely responsible for its contents.
The products/services discussed are for research use only and not for use in diagnostic procedures (except as specifically noted).
